Luan Liqiang, Ding Lanlan, Shi Jiawei, Fang Wenjuan, Ni Yuxing, Liu Wei
State Key Laboratory of Crystal Materials, Shandong University, Jinan, 250100 Shandong (P.R. China).
Chem Asian J. 2014 Dec;9(12):3491-7. doi: 10.1002/asia.201402813. Epub 2014 Oct 9.
To demonstrate the effect of axial ligands on the structure-activity relationship, a series of axially substituted silicon phthalocyanines (SiPcs) have been synthesized with changes to the axial ligands. The reactivity of the axial ligand upon shielding by the phthalocyanine ring current, along with their stability, photophysical, and photodynamic therapy (PDT) activities were compared and evaluated for the first time. As revealed by single-crystal XRD analysis, rotation of the axial -OMe ligands was observed in SiPc 3, which resulted in two molecular configurations coexisting synchronously in both the solid and solution states and causing a split of the phthalocyanine α protons in the (1)H NMR spectra that is significantly different from all SiPcs reported so far. The remarkable photostability, good singlet oxygen quantum yield, and efficient in vitro photodynamic activity synergistically show that compound 3 is one of the most promising photosensitizers for PDT.
为了证明轴向配体对构效关系的影响,合成了一系列轴向取代的硅酞菁(SiPcs),其轴向配体发生了变化。首次比较并评估了轴向配体在酞菁环电流屏蔽下的反应性及其稳定性、光物理和光动力疗法(PDT)活性。单晶XRD分析表明,在SiPc 3中观察到轴向-OMe配体的旋转,这导致两种分子构型在固态和溶液态中同时共存,并使酞菁α质子在(1)H NMR光谱中发生分裂,这与迄今为止报道的所有SiPcs都有显著差异。出色的光稳定性、良好的单线态氧量子产率和高效的体外光动力活性协同表明,化合物3是最有前途的用于光动力疗法的光敏剂之一。